Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00610961 · ClinicalTrials.gov registry record
Induction Related BK Viremia in Renal Transplant Patients
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 60
- Enrollment target
NCT00610961: Completed study, sponsored by University of Florida.
NCT00610961 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00610961 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The increase immunosuppression in our transplant population has led to an unacceptable rate of patients at risk for BK virus nephropathy. Reducing induction immunosuppression by switching from Thymoglobulin to Simulect will reduce the incidence of serum positivity for BK by PCR.
Primary Outcome
BKVV (BK Visus Viremia) titer is measured by PCR at 1, 3,6,9 and 12 month time points.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2007-10 |
| Est. Completion | 2009-11 |
What the finished NCT00610961 record still lists
NCT00610961 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00610961 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00610961 about?
NCT00610961 is a clinical study titled "Induction Related BK Viremia in Renal Transplant Patients". The increase immunosuppression in our transplant population has led to an unacceptable rate of patients at risk for BK virus nephropathy. Reducing induction immunosuppression by switching from Thymoglobulin to Simulect will reduce the incidence of serum positivity for BK by PCR.
What is the current status of trial NCT00610961?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2007-10. Estimated completion is 2009-11.
Who is sponsoring clinical trial NCT00610961?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia